Drug, Insulin Price Caps Head for Showdown Over Senate Rules

Nov. 26, 2021, 6:28 PM

Senate Democrats expect to defend key portions of their drug-pricing agenda against a technical challenge by Republicans as soon as next week, potentially curtailing crucial parts of their social spending and tax package.

Democrats expect to go before the Senate parliamentarian, a nonpartisan official who oversees that chamber’s rules, during the first days in December to get guidance on whether many of the health policy items in their House-passed bill (H.R. 5376) qualify under budget reconciliation, two senior Democratic aides told Bloomberg Government. That process allows legislation to pass in the Senate with a simply majority vote on ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.